MedTrace Logo

Molecular Imaging in Fabry Disease of the Heart

NCT06226987 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2024-07-22

No results posted yet for this study

Summary

Better methods for early detection of cardiac involvement in Fabry disease are needed to inform clinical management decisions that can help prevent or slow the progression of cardiac complications. In the Molecular Imaging of Inflammation in Fabry Disease of the Heart study, the investigators will test the use of 68Ga-DOTATATE PET/MRI for identifying myocardial inflammation in patients with Fabry disease.

Conditions

  • Fabry Disease, Cardiac Variant

Interventions

DIAGNOSTIC_TEST

68Ga-DOTATATE PET/MRI

PET/MRI scanning

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-02
Primary Completion
2026-01-02
Completion
2026-01-02

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06226987 on ClinicalTrials.gov